Your browser doesn't support javascript.
Prognostic Value of Coronary Artery Calcium Score in Hospitalized COVID-19 Patients.
Luchian, Maria-Luiza; Lochy, Stijn; Motoc, Andreea; Belsack, Dries; Magne, Julien; Roosens, Bram; de Mey, Johan; Tanaka, Kaoru; Scheirlynck, Esther; Boeckstaens, Sven; Van den Bussche, Karen; De Potter, Tom; von Kemp, Berlinde; Galloo, Xavier; François, Clara; Weytjens, Caroline; Droogmans, Steven; Cosyns, Bernard.
  • Luchian ML; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • Lochy S; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • Motoc A; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • Belsack D; Department of Radiology, University Hospital of Brussels, Brussels, Belgium.
  • Magne J; CHU Limoges, Hôpital Dupuytren, Service Cardiologie, Limoges, France.
  • Roosens B; INSERM 1094, Faculté de médecine de Limoges, 2, rue Marcland, Limoges, France.
  • de Mey J; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • Tanaka K; Department of Radiology, University Hospital of Brussels, Brussels, Belgium.
  • Scheirlynck E; Department of Radiology, University Hospital of Brussels, Brussels, Belgium.
  • Boeckstaens S; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • Van den Bussche K; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • De Potter T; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • von Kemp B; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
  • Galloo X; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • François C; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • Weytjens C; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • Droogmans S; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
  • Cosyns B; Department of Cardiology, University Hospital of Brussels (Centrum voor Hart-en Vaat ziekten, Universitair Ziekenhuis Brussel), Brussels, Belgium.
Front Cardiovasc Med ; 8: 684528, 2021.
Article in English | MEDLINE | ID: covidwho-1325518
ABSTRACT

Background:

The association of known cardiovascular risk factors with poor prognosis of coronavirus disease 2019 (COVID-19) has been recently emphasized. Coronary artery calcium (CAC) score is considered a risk modifier in the primary prevention of cardiovascular disease. We hypothesized that the absence of CAC might have an additional predictive value for an improved cardiovascular outcome of hospitalized COVID-19 patients. Materials and

methods:

We prospectively included 310 consecutive hospitalized patients with COVID-19. Thirty patients with history of coronary artery disease were excluded. Chest computed tomography (CT) was performed in all patients. Demographics, medical history, clinical characteristics, laboratory findings, imaging data, in-hospital treatment, and outcomes were retrospectively analyzed. A composite endpoint of major adverse cardiovascular events (MACE) was defined.

Results:

Two hundred eighty patients (63.2 ± 16.7 years old, 57.5% male) were included in the analysis. 46.7% patients had a CAC score of 0. MACE rate was 21.8% (61 patients). The absence of CAC was inversely associated with MACE (OR 0.209, 95% CI 0.052-0.833, p = 0.027), with a negative predictive value of 84.5%.

Conclusion:

The absence of CAC had a high negative predictive value for MACE in patients hospitalized with COVID-19, even in the presence of cardiac risk factors. A semi-qualitative assessment of CAC is a simple, reproducible, and non-invasive measure that may be useful to identify COVID-19 patients at a low risk for developing cardiovascular complications.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research Language: English Journal: Front Cardiovasc Med Year: 2021 Document Type: Article Affiliation country: Fcvm.2021.684528

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research Language: English Journal: Front Cardiovasc Med Year: 2021 Document Type: Article Affiliation country: Fcvm.2021.684528